Hazel Stewart
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release
Stewart, Hazel; Palmulli, Roberta; Johansen, Kristoffer H; McGovern, Naomi; Shehata, Ola M; Carnell, George W; Jackson, Hannah K; Lee, Jin S; Brown, Jonathan C; Burgoyne, Thomas; Heeney, Jonathan L; Okkenhaug, Klaus; Firth, Andrew E; Peden, Andrew A; Edgar, James R
Authors
Roberta Palmulli
Kristoffer H Johansen
Naomi McGovern
Ola M Shehata
George W Carnell
HANNAH JACKSON Hannah.Jackson6@nottingham.ac.uk
Research Fellow
Jin S Lee
Jonathan C Brown
Thomas Burgoyne
Jonathan L Heeney
Klaus Okkenhaug
Andrew E Firth
Andrew A Peden
James R Edgar
Abstract
The antiviral restriction factor, tetherin, blocks the release of several different families of enveloped viruses, including the Coronaviridae. Tetherin is an interferon-induced protein that forms parallel homodimers between the host cell and viral particles, linking viruses to the surface of infected cells and inhibiting their release. We demonstrate that SARS-CoV-2 infection causes tetherin downregulation and that tetherin depletion from cells enhances SARS-CoV-2 viral titres. We investigate the potential viral proteins involved in abrogating tetherin function and find that SARS-CoV-2 ORF3a reduces tetherin localisation within biosynthetic organelles where Coronaviruses bud, and increases tetherin localisation to late endocytic organelles via reduced retrograde recycling. We also find that expression of Spike protein causes a reduction in cellular tetherin levels. Our results confirm that tetherin acts as a host restriction factor for SARS-CoV-2 and highlight the multiple distinct mechanisms by which SARS-CoV-2 subverts tetherin function.
Citation
Stewart, H., Palmulli, R., Johansen, K. H., McGovern, N., Shehata, O. M., Carnell, G. W., …Edgar, J. R. (2023). Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release. EMBO Reports, 24(12), Article e57224. https://doi.org/10.15252/embr.202357224
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 1, 2023 |
Online Publication Date | Oct 11, 2023 |
Publication Date | Dec 6, 2023 |
Deposit Date | May 28, 2024 |
Publicly Available Date | May 29, 2024 |
Journal | EMBO Reports |
Print ISSN | 1469-221X |
Electronic ISSN | 1469-3178 |
Publisher | EMBO Press |
Peer Reviewed | Peer Reviewed |
Volume | 24 |
Issue | 12 |
Article Number | e57224 |
DOI | https://doi.org/10.15252/embr.202357224 |
Public URL | https://nottingham-repository.worktribe.com/output/35432130 |
Publisher URL | https://www.embopress.org/doi/full/10.15252/embr.202357224 |
Additional Information | Received: 2023-03-21; Accepted: 2023-09-21; Published: 2023-10-11 |
Files
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
(4.1 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies
(2023)
Journal Article
MEDB-64. Are Rab GTPases metastatic drivers in metastatic medulloblastoma?
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search